Bersani-Amado C A, Barbuto J A, Jancar S
Department of Pharmacy and Biochemistry, University of Maringa, Parana, Brazil.
J Rheumatol. 1990 Jun;17(6):738-42.
In rats of the Holtzman strain, susceptible to the development of adjuvant induced arthritis (AIA), oral administration of BCG significantly inhibited the development of the disease. Oral treatment with purified protein derivative (PPD) had no effect. In the resistant Buffalo rats, however, oral administration of BCG and PPD enhanced the lesions. Since oral administration of antigens has been described to induce suppressor cells, our results suggest that the development of AIA is controlled by suppressor mechanisms, which fail to be activated in the susceptible strain, but are stimulated by the oral administration of BCG.
在易患佐剂诱导性关节炎(AIA)的霍尔茨曼品系大鼠中,口服卡介苗可显著抑制该病的发展。用纯化蛋白衍生物(PPD)进行口服治疗则无效果。然而,在具有抗性的布法罗大鼠中,口服卡介苗和PPD会加重病变。由于已报道口服抗原可诱导抑制性细胞,我们的结果表明,AIA的发展受抑制机制控制,该机制在易感品系中无法被激活,但口服卡介苗可刺激其激活。